6/17/2013

Studies documenting the benefits of PET/MR imaging were among the highlights of the SNMMI Annual Meeting, according to this article. The meeting also included developments related to neurodegenerative imaging -- the stage was set with the approval of amyloid-binding tracer Amyvid, but other tracers also have gained prominence. SNMMI's push to advance global nuclear medicine collaborations was also an important theme.

Full Story:
DOTMed.com

Related Summaries